HomeGeneticsConditionAnkyrin-B syndrome
Back to Condition
Ankyrin-B syndrome
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Condition

Ankyrin-B Syndrome

Ankyrin-B syndrome is a rare genetic heart condition characterized by disruptions in the heart's electrical signaling, leading to various forms of cardiac arrhythmia.

Overview & Symptoms

Ankyrin-B syndrome is associated with a variety of heart problems related to disruption of the heart's normal rhythm (arrhythmia). Heart rhythm is controlled by electrical signals that move through the heart in a highly coordinated way. In ankyrin-B syndrome, disruption of different steps of electrical signaling can lead to arrhythmia, and the resulting heart problems vary among affected individuals.

Individuals with ankyrin-B syndrome may have problems with the sinoatrial (SA) node, which generates the electrical impulses that start each heartbeat. If the SA node is not functioning properly, the heartbeat can be too slow (bradycardia). In a small number of people with ankyrin-B syndrome, the heart takes longer than usual to recharge between beats, which is known as a prolonged QT interval (long QT).

Some affected individuals have impaired progression (conduction) of electrical impulses between the heart chambers, which can cause a problem called heart block. Other heart problems that occur in ankyrin-B syndrome include irregular and uncoordinated electrical activity in the heart's upper chambers (atrial fibrillation) or lower chambers (ventricular fibrillation) and an abnormality called catecholaminergic polymorphic ventricular tachycardia (CPVT), in which an increase in the heart rate can trigger an abnormally fast and irregular heartbeat. In people with ankyrin-B syndrome, arrhythmia can lead to fainting (syncope) or cardiac arrest and sudden death.

When associated with a prolonged QT interval, the condition is sometimes classified as long QT syndrome 4. However, because additional heart problems can result from changes in the same gene, long QT syndrome 4 is usually considered part of ankyrin-B syndrome.

Frequency

Ankyrin-B syndrome is a rare disorder. Its prevalence is unknown.

Causes

Ankyrin-B syndrome is caused by mutations in the ANK2 gene, which provides instructions for making a protein called ankyrin-B. This protein is active in many cell types, including heart (cardiac) muscle cells. The ankyrin-B protein inserts certain structures called ion channels into their proper locations in the cell membrane. Ion channels are complexes of proteins that transport charged atoms (ions) across cell membranes. In the heart, the flow of ions (such as sodium, potassium, and calcium) through ion channels generates the electrical signals that control the heartbeat and maintain a normal heart rhythm.

Mutations in the ANK2 gene lead to production of an altered ankyrin-B protein that cannot target ion channels to their correct locations in cardiac muscle cells. The loss of functional ion channels in the heart disrupts the normal flow of ions, which alters the heart's normal rhythm and causes the heart problems associated with ankyrin-B syndrome.

Not everyone with an ANK2 gene mutation has heart problems related to ankyrin-B syndrome. Researchers speculate that other genes or environmental factors may play a role in development of the condition.

Associated Genes

  • ANK2

Inheritance

Ankyrin-B syndrome is inherited in an autosomal dominant pattern, which means one copy of the altered ANK2 gene in each cell is sufficient to cause the disorder. In most cases, an affected person has one parent with the condition.

Some people who have an altered ANK2 gene never develop heart problems, a situation known as reduced penetrance.

Other Names for This Condition

  • Cardiac arrhythmia, ankyrin-B-related

Frequently Asked Questions

Warning signs can include fainting (syncope), severe dizziness, palpitations (feeling a racing or fluttering heart), or chest pain, especially during physical activity or emotional stress. These could indicate a life-threatening arrhythmia like ventricular fibrillation or catecholaminergic polymorphic ventricular tachycardia (CPVT) and require immediate medical attention.
Treatment depends on the specific arrhythmia. Medications like beta-blockers are often prescribed to slow the heart rate and reduce the risk of dangerous rhythms, particularly for prolonged QT or CPVT. In some cases, an implantable cardioverter-defibrillator (ICD) may be recommended to deliver an electrical shock to correct life-threatening arrhythmias. Pacemakers can help manage severe bradycardia or heart block.
nkyrin-B syndrome is inherited in an autosomal dominant pattern. This means only one copy of the altered ANK2 gene in each cell is sufficient to cause the disorder. Each child of an affected parent has a 50% chance of inheriting the condition. Genetic counseling is highly recommended for affected individuals and their families to understand the risks, discuss testing options for at-risk relatives, and aid in family planning.
Diagnosis often involves a combination of tests. An electrocardiogram (ECG) can detect prolonged QT interval, bradycardia, or heart block. A Holter monitor or event recorder may capture intermittent arrhythmias over time. Exercise stress tests can provoke certain arrhythmias like CPVT. Genetic testing for mutations in the ANK2 gene ultimately confirms the diagnosis. Family history is also crucial.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

kontakt@hittavard.se

Ⓒ 2024. Alla rättigheter förbehålls av juxt ab